| Promising therapeutic targets for treatment of rheumatoid arthritis J Huang, X Fu, X Chen, Z Li, Y Huang, C Liang Frontiers in immunology 12, 686155, 2021 | 262 | 2021 |
| Advances in aptamer-based biomarker discovery J Huang, X Chen, X Fu, Z Li, Y Huang, C Liang Frontiers in Cell and Developmental Biology 9, 659760, 2021 | 75 | 2021 |
| CRISPR/Cas systems: Delivery and application in gene therapy J Huang, Y Zhou, J Li, A Lu, C Liang Frontiers in bioengineering and biotechnology 10, 942325, 2022 | 56 | 2022 |
| Therapeutic Effects of (5R)-5-Hydroxytriptolide on Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via lncRNA WAKMAR2/miR-4478/E2F1/p53 Axis X Zhou, D Xie, J Huang, A Lu, R Wang, Y Jin, R Zhang, C Chang, L Xu, ... Frontiers in immunology 12, 605616, 2021 | 38 | 2021 |
| Toward overcoming treatment failure in rheumatoid arthritis Z Wang, J Huang, D Xie, D He, A Lu, C Liang Frontiers in immunology 12, 755844, 2021 | 34 | 2021 |
| Advances in screening and development of therapeutic aptamers against cancer cells Z Li, X Fu, J Huang, P Zeng, Y Huang, X Chen, C Liang Frontiers in Cell and Developmental Biology 9, 662791, 2021 | 28 | 2021 |
| Organoids as innovative models for bone and joint diseases J Huang, L Zhang, A Lu, C Liang Cells 12 (12), 1590, 2023 | 24 | 2023 |
| Repurposing AS1411 for constructing ANM-PROTACs X Fu, J Li, X Chen, H Chen, Z Wang, F Qiu, D Xie, J Huang, S Yue, C Cao, ... Cell Chemical Biology 31 (7), 1290-1304. e7, 2024 | 9 | 2024 |
| Gut microbial metabolite targets HDAC3-FOXK1-interferon axis in fibroblast-like synoviocytes to ameliorate rheumatoid arthritis H Chen, X Fu, X Wu, J Zhao, F Qiu, Z Wang, Z Wang, X Chen, D Xie, ... Bone Research 12 (1), 31, 2024 | 5 | 2024 |
| Generation of cytotoxic aptamers specifically targeting fibroblast-like synoviocytes by CSCT-SELEX for treatment of rheumatoid arthritis F Qiu, D Xie, H Chen, Z Wang, J Huang, C Cao, Y Liang, X Yang, DY He, ... Annals of the Rheumatic Diseases, 2025 | 2 | 2025 |
| Deciphering and targeting epigenetics in cancer metastasis J Huang, A Lu, C Liang Cancer metastasis-Molecular mechanism and clinical therapy, 2022 | 1 | 2022 |
| Development of hybrid aptamers-engineered PROTACs for degrading VEGF165 in both tumor-and vascular endothelial cells Z Feng, D Xie, F Qiu, J Huang, Z Wang, C Liang European Journal of Medicinal Chemistry 281, 117027, 2025 | | 2025 |
